Cancer

Items 41-50 of 108

per page
Set Descending Direction
  1. FasL (human) (multimeric) (rec.)
    AG-40B-0130
    AG-40B-0130-C01010 µg
    CHF 380.00
    AG-40B-0130-30103 x 10 µg
    CHF 760.00
    Oligomerisation of FasL (h) efficiently triggers Jurkat cell death.Method: Jurkat cells were treated O/N with the indicated concentrations of FasL (human) (multimeric) (rec.) (Prod. No. AG-40B-0130), Fc:FasL, Soluble (human) (rec.) (Prod. No.
  2. FasL, Soluble (human) (rec.)
    AG-40B-0001
    AG-40B-0001-C01010 µg
    CHF 190.00
    AG-40B-0001-30103 x 10 µg
    CHF 385.00
  3. Fc (human):BAFF (human) (rec.)
    AG-40B-0120
    AG-40B-0120-C01010 µg
    CHF 230.00
    AG-40B-0120-30103 x 10 µg
    CHF 460.00
    AG-40B-0120-C500500 µg
    CHF 2'400.00
    Restoration of the splenic T and B cell architecture in Fc-BAFF injected BAFFdeficient mice. BAFF deficient mice were injected at day 0 with 100mg BAFF (human):Fc (human) (AG-40B-0120) intravenously and at day 14 with 50mg BAFF (human):Fc (human) intraper
  4. Fc (human):FasL, Soluble (human) (rec.)
    AG-40B-0132
    AG-40B-0132-C01010 µg
    CHF 335.00
    AG-40B-0132-30103 x 10 µg
    CHF 670.00
    Oligomerisation of FasL (h) efficiently triggers Jurkat cell death.Method: Jurkat cells were treated O/N with the indicated concentrations of MegaFasL, Soluble (human) (rec.) (Prod. No. AG-40B-0130), Fc:FasL, Soluble (human) (rec.) (Pr
  5. Fc (human):FGL1 (mouse) (rec.)
    AG-40B-0185
    AG-40B-0185-C01010 µg
    CHF 240.00
    AG-40B-0185-30103 x 10 µg
    CHF 480.00
    AG-40B-0185-C100100 µg
    CHF 1'140.00
  6. Fc (LALA-PG)-KIH (human):GDF15 (human) (rec.)
    AG-40B-0253
    AG-40B-0253-C05050 µg
    CHF 440.00
    NEW Fc (LALA-PG)-KIH (human):GDF15 (human) (rec.)
  7. Fc (LALA-PG)-KIH (human):GDF15 (mouse) (rec.)
    AG-40B-0245
    AG-40B-0245-C05050 µg
    CHF 440.00
    Fc (LALA-PG)-KIH (human):GDF15 (mouse) (rec.)
  8. FGF-1 (mouse) (rec.) (untagged)
    AG-40B-0148
    AG-40B-0148-C01010 µg
    CHF 120.00
    AG-40B-0148-30103 x 10 µg
    CHF 240.00
  9. Frizzled-5 (human):Fc (human) (rec.)
    AG-40B-0133
    AG-40B-0133-C05050 µg
    CHF 290.00
    AG-40B-0133-30503 x 50 µg
    CHF 575.00
    Figure: Frizzled-5 (human):Fc (human) (rec.) (AG-40B-0133) efficiently inhibits Wnt3a activation. Methods: Inhibition of Wnt3a activation by Frizzled-5 (human):Fc (human) (rec.) was measured by using HEK293 cells transfected with a plasmid c

Items 41-50 of 108

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.